Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000–2014: A Population-based Cohort Study

BACKGROUND: Cisplatin-based chemotherapy (CBCT) in testicular cancer (TC) is associated with elevated venous thromboembolism (VTE) risk, but trials evaluating the safety and efficacy of thromboprophylaxis are lacking. OBJECTIVE: To evaluate the arterial thromboembolism (ATE) and VTE incidence and ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Haugnes, Hege S., Negaard, Helene F., Jensvoll, Hilde, Wilsgaard, Tom, Tandstad, Torgrim, Solberg, Arne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Testis Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505199/
https://www.ncbi.nlm.nih.gov/pubmed/34667955
http://dx.doi.org/10.1016/j.euros.2021.07.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505199/
https://www.ncbi.nlm.nih.gov/pubmed/34667955
http://dx.doi.org/10.1016/j.euros.2021.07.007

Ejemplares similares